Insmed Depreciation And Amortization from 2010 to 2024

INSM Stock  USD 24.16  0.37  1.51%   
Insmed Depreciation And Amortization yearly trend continues to be very stable with very little volatility. Depreciation And Amortization is likely to grow to about 11.1 M this year. Depreciation And Amortization is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. View All Fundamentals
 
Depreciation And Amortization  
First Reported
1999-03-31
Previous Quarter
2.7 M
Current Value
2.9 M
Quarterly Volatility
M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 80.1 M or Total Revenue of 320.5 M, as well as many exotic indicators such as Price To Sales Ratio of 13.55, Dividend Yield of 0.0 or Days Sales Outstanding of 46.8. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
  
This module can also supplement Insmed's financial leverage analysis and stock options assessment as well as various Insmed Technical models . Check out the analysis of Insmed Correlation against competitors.

Latest Insmed's Depreciation And Amortization Growth Pattern

Below is the plot of the Depreciation And Amortization of Insmed Inc over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. Insmed's Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insmed's overall financial position and show how it may be relating to other accounts over time.
Depreciation And Amortization10 Years Trend
Slightly volatile
   Depreciation And Amortization   
       Timeline  

Insmed Depreciation And Amortization Regression Statistics

Arithmetic Mean3,811,635
Coefficient Of Variation159.36
Mean Deviation4,321,970
Median1,982,000
Standard Deviation6,074,375
Sample Variance36.9T
Range25.5M
R-Value0.60
Mean Square Error25.6T
R-Squared0.36
Significance0.02
Slope810,531
Total Sum of Squares516.6T

Insmed Depreciation And Amortization History

202411.1 M
202310.6 M
202219.9 M
2021-5.6 M
20205.4 M
20194.5 M
20181.2 M

About Insmed Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Insmed income statement, its balance sheet, and the statement of cash flows. Insmed investors use historical funamental indicators, such as Insmed's Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although Insmed investors may use each financial statement separately, they are all related. The changes in Insmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Insmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Insmed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Insmed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Depreciation And Amortization10.6 M11.1 M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insmed Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out the analysis of Insmed Correlation against competitors.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Global Correlations
Find global opportunities by holding instruments from different markets
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.15)
Revenue Per Share
2.199
Quarterly Revenue Growth
0.158
Return On Assets
(0.32)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.